6-ethenylquinoline

CAS No. 651025-06-8

6-ethenylquinoline( —— )

Catalog No. M28424 CAS No. 651025-06-8

6-ethenylquinoline is a compound used as a molecular building block.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 98 Get Quote
5MG 152 Get Quote
10MG 228 Get Quote
25MG 390 Get Quote
50MG 574 Get Quote
100MG 803 Get Quote
500MG 1665 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-ethenylquinoline
  • Note
    Research use only, not for human use.
  • Brief Description
    6-ethenylquinoline is a compound used as a molecular building block.
  • Description
    6-ethenylquinoline is a compound used as a molecular building block.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Dopamine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    651025-06-8
  • Formula Weight
    155.2
  • Molecular Formula
    C11H9N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C=Cc1ccc2ncccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hazelhoff B, De Vries JB, Dijkstra D, Mulder TB, Timmermans PB, Wynberg H, Horn AS. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines. Eur J Pharmacol. 1986 May 13;124(1-2):93-106. doi: 10.1016/0014-2999(86)90128-7. PMID: 3720849.
molnova catalog
related products
  • HIV-1 gag Protein p2...

    HIV-1 gag Protein p24 (137-154)

  • OATD-01

    OATD-01 is a highly active inhibitor of both Chitotriosidase (CHIT1) and acidic mammalian chitinase (AMCase).

  • Difopein TFA (396834...

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.